DEBBANE RAYMOND
Transaction: 06/03/2026
SELL
Change
-89,312
Price
Not reported
Filing
06/04/2026
Type
SELL
Lexicon Pharmaceuticals, Inc.
LXRX • Biotechnology
$2.24
▼ -0.02 (-0.88%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.05B
Growth
-8.4%
Cash Flow
0/5
Trend
Negative
Evidence
Positive revenue growth · 186.2%Manageable debt level · 0.58Healthy liquidity · 4.88Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:12 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$2.24
Change-0.88%
Market Cap$1.05B
52W Range1.02 - 2.68
Beta1.05
Gross Margin99.45%
Oper. Margin-98.21%
Profit Margin-101.08%
Debt/Eq0.58
Current Ratio4.88
Quick Ratio4.87
Revenue 5Y-8.40%
Price$2.24
Change-0.88%
Market Cap$1.05B
52W Range1.02 - 2.68
Beta1.05
Gross Margin99.45%
Oper. Margin-98.21%
Profit Margin-101.08%
Debt/Eq0.58
Current Ratio4.88
Quick Ratio4.87
Revenue 5Y-8.40%
Target$6.00
Target Upside167.86%
Target Median$6.00
Target Range6.00 - 6.00
Volume4.89M
Avg Volume3.28M
EPS Surprise0.04
Investment DNA
How strong this company looks for long-term investors
48
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
73/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
52/100
Why this score▼
Positive revenue growth · 186.2%Manageable debt level · 0.58Healthy liquidity · 4.88Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-07
Low
$6.00
Mean
$6.00
Median
$6.00
High
$6.00
Insider Transactions
Recent executive and insider activity
DEBBANE RAYMOND
Transaction: 06/03/2026
BUY
Change
+89,312
Price
Not reported
Filing
06/04/2026
Type
BUY
Amouyal Philippe
Transaction: 06/03/2026
SELL
Change
-89,312
Price
Not reported
Filing
06/04/2026
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| DEBBANE RAYMOND | SELL | -89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| DEBBANE RAYMOND | BUY | +89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| Amouyal Philippe | SELL | -89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| Amouyal Philippe | BUY | +89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| BARKER SAM L | SELL | -89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| BARKER SAM L | BUY | +89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| Cheung Ivan | SELL | -89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| Cheung Ivan | BUY | +89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| SOBECKI CHRISTOPHER J | SELL | -89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| SOBECKI CHRISTOPHER J | BUY | +89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| Sullivan Diane E. | SELL | -89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| Sullivan Diane E. | BUY | +89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| Swain Judith L | SELL | -89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| Swain Judith L | BUY | +89,312 | Not reported | 06/03/2026 | 06/04/2026 |
| Artal Participations S.a r.l. | SELL | — | Not reported | 04/30/2026 | 05/08/2026 |
| Artal Participations S.a r.l. | BUY | +20,421,735 | Not reported | 04/30/2026 | 05/08/2026 |
| DEBBANE RAYMOND | BUY | +35,714 | Not reported | 05/01/2026 | 05/04/2026 |
| DEBBANE RAYMOND | BUY | +43,478 | $1.61 | 05/01/2026 | 05/04/2026 |
| Sullivan Diane E. | BUY | +35,714 | Not reported | 05/01/2026 | 05/04/2026 |
| Sullivan Diane E. | BUY | +43,478 | $1.61 | 05/01/2026 | 05/04/2026 |